The Bio Bridge Initiative

What is the Bio-Bridge Initiative?

The Bio-Bridge Initiative is a partnership between Australia and the Texas Medical Centre (TMC) in Houston, USA.

The aim is to create a two way flow of capital and resources, through collaborations in research, clinical trials and commercialisation.

The partnership links Australian firms and ingenuity to TMC - the largest medical centre within the largest health market in the world – to develop a sustainable growth platform for Australian innovation in medical devices, diagnostics and digital health.

What is the Texas Medical Center (TMC)

The Texas Medical Center (TMC) in Houston, USA, is the largest medical centre in the world and largest employer in Houston, with an extensive campus of 21 hospitals, 50 non-profit organisations and eight academic and research institutions. TMC concentrates its operations and research on genomics, regenerative medicine, innovation, clinical trials and health policy.

The Texas Medical Center Accelerator program (TMCx)

The Bio-Bridge Initiative provides Australian medical technology firms a place in the four month Texas Medical Center (TMC) Accelerator Program (TMCx) .

This allows startups a workspace within the world's largest medical center, access to a network of over 120 expert advisers from the 21 Texas Medical Center hospitals and a tailored curriculum, to clinically validate products and establish US market fit for their solutions.

Participants benefit by attending a variety of workshops and hands-on events to gain insights from experts in every facet of running a health-related business in the US, including: clinical trials, FDA regulations, HIPAA/HITECH compliance, hospital procurement, commercial pilots, intellectual property, licensing, fundraising, marketing and other critical areas.

In addition, participants work with the TMCx team to refine strategies and build relationships across the Texas Medical Center. Companies have the opportunity to network with key thought leaders and mentors during the Advisor Pitch Event, the TMC Expert Forum and other scheduled sessions.

The four-month program culminates with TMCx Demo Day, an exclusive presentation to hundreds of investors, corporate partners, hospital stakeholders, media and other guests.

As part of the short term objective of the Bio-Bridge initiative, TMC invites 4-6 Australian innovative SMEs into the TMC Accelerator program (TMCx). This is a competitive process, however Australian companies are invited through a separate process where you will compete and be assessed against other Australian firms only.

This program is offered at NO participation cost to successful companies and TMC does not retain equity.

Hear from previous participants

Stuart Ward, CEO of Ward MM and Ken Saman, CEO of Personify Care share insights from their recent participation in TMCx.

Video

Insights from Harris A. Eyre, CMO of CNSDose

Insights from Harris A. Eyre, CMO of CNSDose

Insights from Stuart Ward, CEO of Ward MM

Insights from Stuart Ward, CEO of Ward MM

Insights from Ken Saman, CEO of Personify Care

Insights from Ken Saman, CEO of Personify Care

For enquiries and more information contact us